Olivier Laureau, President at Servier Foundation and Servier Group, shared on LinkedIn:
“A few days after closing the acquisition of Edgewise Therapeutics, I had the great pleasure of meeting and officially welcoming our new colleagues in Boston.
Welcome to Servier! Together, we are opening a new chapter, united by a shared ambition: making a greater impact for patients living with rare neuromuscular diseases.
With this new expertise, we are strengthening our capabilities and expanding our horizons. Our values, our culture, and our common purpose will make us stronger together.
More than ever, this experience reminded me that talented people are what truly make the difference. I was inspired by the expertise, commitment, and ambition displayed during this US welcome session, as well as by our shared determination to innovate for patients.
Let’s build this next chapter together with a fantastic Team Servier and continue our Servier 2030 journey, advancing therapeutic progress for the benefit of patients.”
